OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IOVA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IOVA is expected to report earnings to fall 20.70% to -26 cents per share on November 06

Iovance Biotherapeutics IOVA Stock Earnings Reports

Q3'25

Est.

$-0.26

Q2'25

Missed

by $0.05

Q1'25

Missed

by $0.12

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

The last earnings report on August 07 showed earnings per share of -33 cents, missing the estimate of -28 cents. With 8.87M shares outstanding, the current market capitalization sits at 763.51M.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

IOVA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IOVA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOVA showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biotechnological products for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

825 Industrial Road

Phone

+1 650 260-7120

Employees

557

Web

https://www.iovance.com